Repositioning Candidate Details

Candidate ID: R0004
Source ID: DB00009
Source Type: approved
Compound Type: biotech
Compound Name: Alteplase
Synonyms: Alteplase; Alteplase (genetical recombination); Alteplase, recombinant; Alteplase,recombinant; Plasminogen activator (human tissue-type protein moiety); rt-PA; t-PA; t-plasminogen activator; Tissue plasminogen activator; Tissue plasminogen activator alteplase; Tissue plasminogen activator, recombinant; tPA
Molecular Formula: --
SMILES: --
DrugBank Description: Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells
CAS Number: 105857-23-6
Molecular Weight:
DrugBank Indication: For management of acute myocardial infarction, acute ischemic stroke and for lysis of acute pulmonary emboli.
DrugBank Pharmacology: Alteplase binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin. It also produces limited conversion of plasminogen in the absence of fibrin.
DrugBank MoA: Alteplase binds to fibrin rich clots via the fibronectin finger-like domain and the Kringle 2 domain. The protease domain then cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action.
Targets: Plasminogen activator; Fibrinogen alpha chain; Urokinase plasminogen activator surface receptor; Plasminogen activator inhibitor 1
Inclusion Criteria: Indication associated